Product Information
SUTAB 1.479-0.225-0.188 GM TAB is a brand product labeled by Braintree Laboratories, Inc., priced at $6.7395 per EA under NDC 52268020101. Its NADAC has been published 290 times since Mar 17, 2021.
FDA first approved this application on Nov 10, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
SUTAB 1.479-0.225-0.188 GM TAB
sodium sulfate, magnesium sulfate, and potassium chlorideStrength
2.7; 2.25; 17.75 g/1; g/1; g/1
Manufacturer
Braintree Laboratories, Inc.NDC
52268020101
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
MAGNESIUM SULFATE ANHYDROUS; POTASSIUM CHLORIDE; SODIUM SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA213135FDA Approved
11/10/2020
TE Code
AB
On Market Since
11/10/2020
Pharmacological Classes
Price Statistics
The NADAC for SUTAB 1.479-0.225-0.188 GM TAB has been published 290 times since Mar 17, 2021, and over the history we have for it it has risen 12.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.7395 per EA |
|---|---|
| All-time high | $6.7483 (May 14, 2025) |
| All-time low | $5.9751 (Mar 17, 2021) |
| 52-week high | $6.7428 |
| 52-week low | $6.7265 |
| Median price | $6.3704 |
| Average price | $6.4265 |
| Largest weekly change | +3.0% (Jan 11, 2023) |
| Weeks tracked | 290 |
| Tracking since | Mar 17, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the sodium sulfate, magnesium sulfate, and potassium chloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Braintree Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sodium sulfate, magnesium sulfate, and potassium chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calculi Dissolution Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUTAB 1.479-0.225-0.188 GM TAB?
The current National Average Drug Acquisition Cost (NADAC) for SUTAB 1.479-0.225-0.188 GM TAB, manufactured by Braintree Laboratories, Inc., is $6.7395 per EA (NDC 52268020101), effective Sep 30, 2026.
How has the price of SUTAB 1.479-0.225-0.188 GM TAB changed over time?
Over the history we have for it, the NADAC for SUTAB 1.479-0.225-0.188 GM TAB has risen 12.8%. It has been tracked across 290 weekly CMS publications since Mar 17, 2021.
What are the highest and lowest recorded NADAC prices for SUTAB 1.479-0.225-0.188 GM TAB?
Since Mar 17, 2021, the NADAC for SUTAB 1.479-0.225-0.188 GM TAB has ranged from a low of $5.9751 (Mar 17, 2021) to a high of $6.7483 (May 14, 2025), with a median of $6.3704 per EA.
Are there cheaper alternatives to SUTAB 1.479-0.225-0.188 GM TAB?
No other NADAC-published product currently shares the active ingredient and strength of SUTAB 1.479-0.225-0.188 GM TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SUTAB 1.479-0.225-0.188 GM TAB?
SUTAB 1.479-0.225-0.188 GM TAB (NDC 52268020101) is labeled by Braintree Laboratories, Inc., and CMS classifies it as a brand product.